A mathematical analysis of serological data has provided the basis for a new serotyping routine. This paper describes the process whereby the results of agglutination reactions between the standard O antigens of Escherichia coli and rabbit antisera raised against them were used to produce a much simpler, faster, and cheaper method of serotyping. This new method for serotyping E. coli requires on average only one-fifth of the serum used in the previous method and requires less than half the laboratory time. By using this method, an efficient serotyping routine can be established for any set of comparable data regardless of the bacterial group.
A mathematical analysis of serological data has provided the basis for a new serotyping routine. This paper describes the process whereby the results of agglutination reactions between the standard O antigens of Escherichia coli and rabbit antisera raised against them were used to produce a much simpler, faster, and cheaper method of serotyping. This new method for serotyping E. coli requires on average only one-fifth of the serum used in the previous method and requires less than half the laboratory time. By using this method, an efficient serotyping routine can be established for any set of comparable data regardless of the bacterial group.
Many bacterial groups are characterized by their serological reactions. In general, when the serological reactions between different members of a group are tested against each other, there are some, but not many, cross-reactions. An example of such a group is Escherichia coli.
The pioneering work of Kauffmann in the 1940s first led to the establishment of an internationally accepted serotyping scheme for strains of E. coli (8) (9) (10) (11) . While initially only 20 different O antigens were described, the number has subsequently increased to over 160, with new types being described from time to time. The serology, chemistry, and genetics of these were reviewed by 0rskov et al. (14) , who brought together most of the recent studies on these antigens.
While E. coli organisms are present in the bowels of humans and most other warm-blooded animals, some types can also cause diseases including infantile gastroenteritis, traveler's diarrhea, and various similar illnesses of domestic animals (18) . In addition, nonenteric human infections including urinary tract infections, meningitis, and wound infections have been documented (2, 7) . To differentiate the pathogenic types from the nonpathogens, serotyping has been used. In addition, during outbreaks, serotyping is an invaluable tool for demonstrating the relationship between the different strains in the environment and the infected hosts (3) .
A streamlined method for identifying the serotype of an unknown strain of E. coli was sought because large costs are involved in the production and maintenance of a serum collection. If significantly less serum were used in the serotyping process, these costs could be substantially reduced. In addition, the methods currently in use are relatively time-consuming. This paper describes how a new, faster serotyping routine, which uses on average one-fifth of the amount of serum used in the current routine, was devised. The investigations which led to the establishment of this new method and the steps which are required to implement it for a specific serum collection are detailed.
A companion paper (4) describes the implementation and verification of this serotyping method.
MATERIALS AND METHODS
The current method of E. coli identification involves the use of pools of sera to narrow the field of possible serogroups for the unknown strain (12; K. A. Bettelheim, Ph.D. thesis, University of London, London, England, 1969).
The data. The data used were those pertaining to the 159 standard O antigens of E. coli and the 159 rabbit antisera raised against them which make up the E. coli O serum collection held at the National Health Institute, Wellington, New Zealand. The levels of all possible agglutination reactions between these 159 0 antigens and their 159 antisera have been determined in extensive laboratory experiments. When the result of an individual experiment was positive, it was given as the titer of the agglutination reaction, i.e., the highest dilution at which a positive reaction could be detected, when the dilutions had been successively doubled. The lowest level of dilution used was 1:100. Weaker reactions were deemed to be negative.
A 159-by-159 response matrix was formed with a blank for a negative result and the reciprocal titer of the reaction for a positive result. Each column of the response matrix represents one serum, and nonblank entries are the reciprocal titer values for reactions between that serum and each antigen which reacts in it. Each row of the response matrix represents one antigen, and nonblank entries are the reciprocal titer values for reactions between the given antigen and each serum. Table 1 gives an 8-by-8 subset of the data matrix used in the early stages of the investigation, showing the reactions of the standard antigens 01 to 08 in the sera 01 to 08. This is simply the top left hand corner of the response matrix.
The 159-by-159 matrix of the revised data to which our final solution applies had the following characteristics: (i) it was sparse (only 646 of the 25,281 positions were filled); (ii) the leading diagonal was full; and (iii) it was nonsymmetric.
Other approaches considered. Before arriving at the final solution, I tried two other methods of analysis. While these did not solve the problem, their performance in this context is worth noting.
(i) Cluster analysis. The data were studied by cluster analysis to investigate the taxonomic aspects of the current SEROTYPING E. COLI: DEVELOPING A NEW METHOD 775 Antigen   01  02  03  04  05  06  07  08   01 6,400 3,200  02  25,600  100   03  100 51,200  04  51,200  05  12,800  400 200  06  12,800   07   400  12,800   08  6,400 a These data were used in the pilot study.
(il) Dissimilar pools. It was considered that the current pooling method could be improved by making use of the cross-reaction information presently ignored.
Consider the serum material to be divided into g pools. Each pool will yield either a positive or a negative result after incubation with the unknown strain. There are 2g possible outcomes of the experiment. If the pools were chosen such that each of these 2g experimental outcomes indicated a minimal set of possible antigens for the unknown strain, serum would be saved. Owing to the existence of cross-reactions, some sera could be dropped from the pools, saving further serum. A program was written in Burroughs Algol for use with a B6700 computer to sift through the possibilities for pool membership. The 159 sera were initially assigned to g = 8 pools in order of serum number. For each of the 256 theoretically possible outcomes, the program sifted through the data, finding (if possible) the set of antigens which could yield the result being considered. Table 2 gives a comparison of the two data sets in terms of the response matrices. Thus, given the nature of the data set, it was considered unlikely that the Genkey approach alone would solve the problem. It would, however, provide a starting point.
The program selects a sequence of tests which divide the data into subsets successively until the subsets each contain only one taxon or until all the tests have been used. The best test is taken as that with a minimum value of some selection criterion function (16) .
A number of such functions are provided in the Genkey program. Because unequal input probabilities were being used, the appropriate selection criterion function was the Shannon entropy criterion function given by the following equation:
largest endpoint for the experimental outcomes having five members. Further computing yielded a solution with 85 sera in seven pools, with the largest endpoint having only four members. This was subjected to laboratory trials, but the results were disappointing, because reactions which had not been anticipated were appearing in mixtures. One possible explanation is that a low-level reaction, perhaps present in an individual serum at 1:50 dilution, could be adding with another low-level reaction to show a positive reaction in the 1:100 dilution mixture. A further possibility could be interference of cross-reactions between sera of which very little is known. In the current pooling method, such misleading where the current subset is considered to be numbered from 1 to m, n is the number of levels of the test, and pu = sjqij, where si is the probability that a specimen at that node belongs to taxon i and qij is the probability that a specimen of taxon i would give responsej to the test. This is the expected entropy of the probabilities of the taxa after the test has been used.
A pilot study was done by using Genkey to construct a diagnostic key to the 8-by-8 subset of the response matrix given in Table 1 . Reactions with reciprocal titers of 100 were assumed to be 50% repeatable. Reactions with reciprocal titers of 200 were assumed to be 75% repeatable. The resulting key, as produced by Genkey, is shown in Fig. la . A binary tree diagram of the same information is given in Fig. lb .
Since each test requires 24 h of elapsed time, sequential testing would not be appropriate in this application. However, the information given in this key can be presented as a table giving all possible reactions of the data to the test sera.
The tests can then all be performed at once, and the results can be compared with the entries in the table to find the corresponding endpoint. In keeping with standard practice, all identifications are then confirmed by direct titration. To illustrate this, Table 3 is the diagnostic table for Note that this approach depends on specific cross-reaction information. While a serum always reacts with its own homologous antigen and may regularly have certain crossreactions, other cross-reactions appear to be more random, and the levels at which they occur can vary from batch to batch. Consequently, it follows that any solution found by this approach would be pertinent only to the specific serum collection which provided the data.
Since the present data set had been accumulated over a number of years, the decision was taken to retest the current serum collection against the standard antigens by using current techniques to produce an up-to-date data set. It should be noted that when a new batch of serum is made in the future, it will be necessary to substitute the new values in the corresponding column of the response matrix and rework the mathematical process to update the identification procedure. This, however, is a minor task and should not present any problems.
Coding the revised data for Genkey. Responses were classed into the following four categories: (i) strong reactions, which would be repeatable even with the serum losing strength by an allowable 1 level of dilution (400 and higher reciprocal titers); (ii) moderately weak reactions, which were assumed to have some associated probability of nonrepeatability (200 reciprocal titer assumed to be 85% repeatable); (iii) weak reactions, which were assumed to have a higher probability of nonrepeatability (100 reciprocal titer assumed to be 75% repeatable); and (iv) negative responses. Categories (ii) and (iii) are called variable responses. IG. 2. The assembled Genkey output illustrating the shape of the diagnostic key when the whole data set was used. The arrow indicates a change in the efficiency of the key.
too pessimistic in setting these values, however, could lead to an inefficient choice of tests for the key.
The analysis. In the absence of distributional information on the occurrence ofE. coli, ail taxa were taken to be equally likely in the beginning and accordingly were assigned a probability of 1/159 of matching the unknown strain (by the program). The criterion function was evaluated over the whole set of possible antigens, and the best test was chosen.
After application of this test, the field of possibilities for the unknown strain was split into two groups: one group comprising antigens not eliminated if the unknown strain responds negatively to the given test and the other group comprising antigens not eliminated if the unknown strain responds positively to the given test. Within each of these two subsets of the data, there is an associated probability for each individual according to how it reacted in the first test. Taking just one of the subsets, the program uses these probabilities as prior probabilities and recalculates the criterion function for members of that subset to find the next best test to split this subset. The process continues down the branch so formed until it can go no farther and then comes back and completes the other branches. This is called branch-by-branch key construction. When the process is completed, identified taxa and any remaining multitaxa are printed with associated probabilities. Genkey was run on the whole data set. As anticipated, the resulting key was huge. All The final solution to the problem became apparent after looking at the Genkey output more closely. Figure 2 is a reduced photograph of the output after the sheets from the lineprinter had been assembled. There was a distinct change in the pattern formed by the printed diagnostic key after about 30 tests had been used. Beyond this region, tests typically yielded only one endpoint per test. From this observation, it was postulated that the data left unidentified after the application of the first 30 or so tests had different properties from those identifiable before the change. A cutoff point of 31 was chosen for reasons of laboratory convenience. The sera used for the 31 best tests would be the "key" sera. The Genkey program was rerun, restricting it to use only the chosen 31 tests (see Appendix B for program). The resulting diagnostic key in effect partitioned the data into the following three categories: (i) the 69 antigens which would definitely be identified by these 31 tests; (ûi) the 31 antigens which may or may not be identified by these 31 tests; and (iii) the 59 antigens which could not be identified by these 31 tests. Categories (ii) and (iii) together make up the possible multitaxon for the unknown strain if the responses to all 31 tests are negative. Category (iii) includes all the 51 antigens which will react only in their own serum. They have been called solos. The remaining eight in this group are the only antigens aside of the solos which will not react with any of the 31 key sera. Furthermore, they have very few cross-reactions.
Tests against the 31 key sera are day 1 tests in the identification procedure and should provide a small set of possibilities for the unknown strain in approximately 65% of cases. A diagnostic table (as presented in Table 3 for the pilot study) was prepared that presented all the possible reactions of the data with the 31 key sera. Multiple endpoints were given with associated probabilities within the multitaxon. (The Genkey code for the production of the probabilistic diagnostic Constructing the intersecting pools for day 2 tests. It was desirable to limit the elapsed time for an identification to 3 days, which is the time taken to complete an identification by the current method. As for the current method, the new method would still require confirmation by titration of the possible antigens against their own sera for the final identification. To conserve serum, day 2 tests should not attempt to cover all 90 possible antigens, because some of these will be in this group only on rare occasions. To reduce the number of sera from 90, use was made of the probabilities associated with each member of the possible unidentified multitaxon which were printed out at the end of the restricted Genkey run. By inspecting the lowest probabilities, it was possible to establish the antigens which had been allowed by the key to fail one or more 1:200-level reactions. The sera corresponding to these antigens were not considered necessary for day 2 pools. The probabilities higher than these corresponded to failure of just one 1:100 test on the appropriate branch of the key, and the highest probabilities were associated with the 59 antigens not reacting at all with the key sera. Both of these cases were retained for day 2 tests. The corresponding test by taxon subset was inspected for redundancies, and further sera were removed from the list as they were covered by cross-reactions at .1:400 dilution by others in the group. This left 59 sera for pooling (only coincidentally the same number as the 59 above).
The 59 sera were arranged into 11 pools ( Table 4 ). Note that each of the 59 individuals is represented once and only once by all possible intersections of two pools (including a single pool positive, which locates the unique member of that pool). A summary of al] possible intersections of these pools was prepared, giving also, when appropriate, antigens which could trigger a positive reaction in two or more pools as a result of a cross-reaction. From the 59 possible intersections of two pools, 67 antigens could be identified.
Following screening through the 11 pools, the possibilities for still no identification fell into two categories: (i) antigens which failed to show positive in the day 1 tests at 1:100 dilution despite their original reaction reciprocal titer being 200 (expected to be very rare) and (ii) antigens whose original test reactions were at 1:400 dilution but which failed to react in the 1:400 dilution pools. These two categories comprised 28 antigens. At this stage, a choice of two approaches could be made depending on how critical it is to not exceed 3 days for final identification: (i) 28 titrations could be done; or (ii) a second set of pools could be used and the final one or two titrations could be done on day 4.
The 28 sera corresponding to the remaining possible 28 antigens can be arranged in seven pools in a similar fashion to that shown in Table 4 . A tabulation of the data for the 28 antigens versus their 28 corresponding sera showed only one cross-reaction, with a reciprocal titer of 400. The lowest homologous titer was 1:400. The pools can therefore be operated at 1:400 dilution. If all these pools react negatively to the unknown strain, two possibilities remain: (i) the unknown strain is any antigen relying on a 1:400 homologous titer to be repeatable in a 1:400 test ( in this application, there was one such antigen); and (ii) the strain is untypable, probably belonging to a new serogroup.
Clearly, if there are more than about two antigens in the day 2 pools that relied on the repeatability of a 1:400 self-reaction, consideration should be given to operating the pools at 1:200. All possible identifications are now covered.
RESULTS AND DISCUSSION This problem was one for which a single approach to the solution was not appropriate. Computer programs for constructing keys to taxa will improve only on sequential testing when there is some cross-reaction information. Pooling works best with no cross-reaction information. By first using the methods of key construction to sweep out the crossreaction information, it was possible to produce a remainder data set suitable for pooling with a minimum of crossreactions.
Laboratory trials have verified that this new method is working without a flaw. Savings in laboratory time are being observed, as well as the expected savings in serum usage (savings are estimated in Appendix D). The method lends itself particularly well to an outbreak situation, for which many of the strains for serotyping can be expected to be the same. In this case, only a sample of the strains yielding the same outcome pattern from the screening for key sera need be titrated to yield a highly likely answer for the dominant strain in the outbreak in minimum time and with minimum effort.
The savings in terms of costs are very large. The new identification routine is simple to use. The tables of possible antigens which have been produced for each phase of the routine could be loaded on a microcomputer in the laboratory, making the process of using the new method even simpler than it is at present.
It is likely that serotyping problems of other bacterial groups for which the test by taxon response matrix is sparse would respond to this dual approach. (The block of data above gives the reactions between antigen Qi and each of the 159 sera. There were 157 further blocks of data for each of the intervening 157 antigens before the last block given below.) i  2  2  2  2  2  2  2  2  2  2  1  1  2  2  2  2  2  2  2  2  2  2  2  2  1  2  2  2  2  2  2  1  2  2  2  2  1  2  2  2  2  1  2  2  2  2  2  i  2  1   2  1  2  2  2  2  2  2  2  2  2  1  1  2  2  2  2  2  2  2  1  2  2 This run produces the full print-out of the data, the probabilistic diagnostic table (printing only endpoints with effectively nonzero-associated probabilities), the number of times each test occurs in the key, the number of times each taxon occurs in the key, the diagnostic key in words, and the diagnostic key in diagram form as in Fig. la pul]). The total amount of serum used is 29.5 to 30.0 pul, with an average of 29.7 pul. The estimated probability of making an identification after day 2 is very roughly 0.3.
Day 3. The amount of serum used on days 1 and 2 (all results negative) is 29.0 pul. For the pools method, seven pools contain 49 units of serum to be used at 1:400 dilution (serum used, 6.1 pul). With one final titration, the amount of serum used is 0.5 pul. For the direct method, 28 titrations are done (serum used, 14.0 puI). The total amount of serum used is 35.6 to 43.0 pul. The estimated probability of needing the day 3 test is very roughly 0.05. Therefore, the expected serum usage varies between approximately 21 and 23 puI, with an average of approximately 21.6 pil, assuming that about half the time on needing day 3 tests the direct method will be chosen. 
